Discerning regulation of cis- and trans-presentation of CD8+ T-cell epitopes by EBV-encoded oncogene LMP-1 through self-aggregation

  • Corey Smith
    Australian Centre for Vaccine Development and Tumour Immunology Laboratory, Division of Immunology, Queensland Institute of Medical Research, Brisbane, Australia; and
  • Naohiro Wakisaka
    Division of Otolaryngology, Graduate School of Medicine, Kanazawa University, Kanazawa, Japan
  • Tania Crough
    Australian Centre for Vaccine Development and Tumour Immunology Laboratory, Division of Immunology, Queensland Institute of Medical Research, Brisbane, Australia; and
  • Jesse Peet
    Australian Centre for Vaccine Development and Tumour Immunology Laboratory, Division of Immunology, Queensland Institute of Medical Research, Brisbane, Australia; and
  • Tomokazu Yoshizaki
    Division of Otolaryngology, Graduate School of Medicine, Kanazawa University, Kanazawa, Japan
  • Leone Beagley
    Australian Centre for Vaccine Development and Tumour Immunology Laboratory, Division of Immunology, Queensland Institute of Medical Research, Brisbane, Australia; and
  • Rajiv Khanna
    Australian Centre for Vaccine Development and Tumour Immunology Laboratory, Division of Immunology, Queensland Institute of Medical Research, Brisbane, Australia; and

書誌事項

公開日
2009-06-11
資源種別
journal article
DOI
  • 10.1182/blood-2009-02-203687
公開者
American Society of Hematology

この論文をさがす

説明

<jats:title>Abstract</jats:title><jats:p>Activation of the nuclear factor–κB pathway by Epstein-Barr virus–encoded latent membrane protein-1 (LMP-1) leads to an up-regulation of the major histocompatibility complex class I antigen–processing pathway. Paradoxically, LMP-1 itself induces a subdominant CD8+ T-cell response and appears to have evolved to avoid immune recognition. Here we show that, although expression of LMP-1 in human cells dramatically enhanced the trans-presentation of CD8+ T-cell epitopes, cis-presentation of LMP-1–derived epitopes was severely impaired. Testing of a series of LMP-1 mutants revealed that deletion of the first transmembrane domain of LMP-1, which prevented self-aggregation, significantly enhanced cis-presentation of T-cell epitopes from this protein, whereas it lost its ability to up-regulate trans-presentation. Interestingly, we also found that cis-presentation of LMP-1 epitopes was rescued by blocking the proteasome function. Taken together, these results delineate a novel mechanism of immune evasion, which renders a virally encoded oncogene inaccessible to the conventional major histocompatibility complex class I pathway limiting its cis-presentation to effector cells.</jats:p>

収録刊行物

  • Blood

    Blood 113 (24), 6148-6152, 2009-06-11

    American Society of Hematology

被引用文献 (10)*注記

もっと見る

参考文献 (25)*注記

もっと見る

関連プロジェクト

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ